Moderna raises $2 billion in convertible notes for general corporate purposes, not a dedicated cancer-vaccine fund

SentiSense · Published · Updated

Moderna launched a $2.0 billion Rule 144A private placement of convertible senior notes due 2032, with an option for up to $300 million more. The stat...

Sign in to read the full story. Free accounts include 20 full reads a month.

Sign in or create a free account

Powered by SentiSense - Intelligent Market Analysis